These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1046 related articles for article (PubMed ID: 29325634)
21. Dynamic Changes of CHA2DS2-VASc Score and the Risk of Ischaemic Stroke in Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study. Yoon M; Yang PS; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B Thromb Haemost; 2018 Jul; 118(7):1296-1304. PubMed ID: 29723875 [TBL] [Abstract][Full Text] [Related]
22. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study. Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219 [TBL] [Abstract][Full Text] [Related]
23. Comparison of Clinical Outcomes Among Patients With Atrial Fibrillation or Atrial Flutter Stratified by CHA2DS2-VASc Score. Lin YS; Chen YL; Chen TH; Lin MS; Liu CH; Yang TY; Chung CM; Chen MC JAMA Netw Open; 2018 Aug; 1(4):e180941. PubMed ID: 30646091 [TBL] [Abstract][Full Text] [Related]
24. Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation: A Nationwide Cohort Study From Taiwan. Chao TF; Wang KL; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Liao JN; Chen TJ; Chiang CE; Lip GY; Chen SA J Am Coll Cardiol; 2015 Sep; 66(12):1339-47. PubMed ID: 26383720 [TBL] [Abstract][Full Text] [Related]
25. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project. Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935 [TBL] [Abstract][Full Text] [Related]
27. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study. Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375 [TBL] [Abstract][Full Text] [Related]
28. Is an Oral Anticoagulant Necessary for Young Atrial Fibrillation Patients With a CHA2DS2-VASc Score of 1 (Men) or 2 (Women)? Hung Y; Chao TF; Liu CJ; Tuan TC; Lin YJ; Chang SL; Lo LW; Hu YF; Liao JN; Chung FP; Lin WY; Lin WS; Cheng SM; Chen TJ; Lip GY; Chen SA J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27702803 [TBL] [Abstract][Full Text] [Related]
29. The predictive role of CHA2DS2-VASc score between venous thromboembolism and ischemic stroke: a large-scale cohort study. Hu WS; Lin CL J Hypertens; 2018 Mar; 36(3):628-633. PubMed ID: 28858980 [TBL] [Abstract][Full Text] [Related]
30. Additional value of left atrial appendage geometry and hemodynamics when considering anticoagulation strategy in patients with atrial fibrillation with low CHA Lee JM; Kim JB; Uhm JS; Pak HN; Lee MH; Joung B Heart Rhythm; 2017 Sep; 14(9):1297-1301. PubMed ID: 28559088 [TBL] [Abstract][Full Text] [Related]
31. Importance of Risk Reassessment in Patients With Atrial Fibrillation in Guidelines: Assessing Risk as a Dynamic Process. Chang TY; Lip GYH; Chen SA; Chao TF Can J Cardiol; 2019 May; 35(5):611-618. PubMed ID: 31030863 [TBL] [Abstract][Full Text] [Related]
32. Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort. Shantsila E; Wolff A; Lip GY; Lane DA Br J Gen Pract; 2015 Jan; 65(630):e16-23. PubMed ID: 25548312 [TBL] [Abstract][Full Text] [Related]
33. Hyperuricemia and the risk of ischemic stroke in patients with atrial fibrillation--could it refine clinical risk stratification in AF? Chao TF; Liu CJ; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Tsao HM; Chen SA Int J Cardiol; 2014 Jan; 170(3):344-9. PubMed ID: 24290426 [TBL] [Abstract][Full Text] [Related]
34. Refining Prediction of Atrial Fibrillation-Related Stroke Using the P Maheshwari A; Norby FL; Roetker NS; Soliman EZ; Koene RJ; Rooney MR; O'Neal WT; Shah AM; Claggett BL; Solomon SD; Alonso A; Gottesman RF; Heckbert SR; Chen LY Circulation; 2019 Jan; 139(2):180-191. PubMed ID: 30586710 [TBL] [Abstract][Full Text] [Related]
35. CHA Hu WS; Lin CL Int J Cardiol; 2017 May; 235():56-60. PubMed ID: 28262350 [TBL] [Abstract][Full Text] [Related]
36. Predictive value of CHA2DS2-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant). Gažová A; Leddy JJ; Rexová M; Hlivák P; Hatala R; Kyselovič J Medicine (Baltimore); 2019 Aug; 98(31):e16560. PubMed ID: 31374021 [TBL] [Abstract][Full Text] [Related]
37. Anticoagulation for atrial fibrillation patients with the CHA2DS2-VASc score =1 (beyond sex). Xie X; Li T Acta Cardiol; 2021 May; 76(3):258-264. PubMed ID: 32056508 [TBL] [Abstract][Full Text] [Related]
38. Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA Rivera-Caravaca JM; Roldán V; Esteve-Pastor MA; Valdés M; Vicente V; Marín F; Lip GYH Am Heart J; 2018 Mar; 197():27-34. PubMed ID: 29447781 [TBL] [Abstract][Full Text] [Related]
39. Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated? Fauchier L; Clementy N; Bisson A; Ivanes F; Angoulvant D; Babuty D; Lip GY Stroke; 2016 Jul; 47(7):1831-6. PubMed ID: 27231269 [TBL] [Abstract][Full Text] [Related]
40. Atrial fibrillation and the risk of ischemic stroke: does it still matter in patients with a CHA2DS2-VASc score of 0 or 1? Chao TF; Liu CJ; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Wu TJ; Chen TJ; Tsao HM; Chen SA Stroke; 2012 Oct; 43(10):2551-5. PubMed ID: 22871677 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]